These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 12451366

  • 1. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
    Lowe NJ, Lask G, Yamauchi P, Moore D.
    J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B, Rzany BJ, Grover R.
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR, Arad S.
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [Abstract] [Full Text] [Related]

  • 8. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A, Carruthers J, Cohen J.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [Abstract] [Full Text] [Related]

  • 9. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Apr; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
    Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J.
    Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
    [Abstract] [Full Text] [Related]

  • 18. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.
    Ito H, Ito H, Nakano S, Kusaka H.
    Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
    Monheit G, Carruthers A, Brandt F, Rand R.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.